5.70
+0.18(+3.26%)
Currency In USD
| Previous Close | 5.52 |
| Open | 5.57 |
| Day High | 5.78 |
| Day Low | 5.45 |
| 52-Week High | 56.04 |
| 52-Week Low | 5.42 |
| Volume | 161,275 |
| Average Volume | 509,934 |
| Market Cap | 53.45M |
| PE | -0.61 |
| EPS | -9.42 |
| Moving Average 50 Days | 33.42 |
| Moving Average 200 Days | 22.13 |
| Change | 0.18 |
If you invested $1000 in Korro Bio, Inc. (KRRO) since IPO date, it would be worth $8.32 as of November 28, 2025 at a share price of $5.7. Whereas If you bought $1000 worth of Korro Bio, Inc. (KRRO) shares 5 years ago, it would be worth $3.97 as of November 28, 2025 at a share price of $5.7.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Korro to Participate in Upcoming Investor and Scientific Conferences
GlobeNewswire Inc.
Sep 02, 2025 8:30 PM GMT
CAMBRIDGE, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) today announced that members of management will participate in the following upcoming investor and scientific conferences for the month of September: Citi's
Korro Receives European Medicines Agency Orphan Drug Designation for KRRO-110
GlobeNewswire Inc.
Jul 21, 2025 12:00 PM GMT
CAMBRIDGE, Mass., July 21, 2025 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA for both rare and highly prevalent di
Korro Appoints Biotech Industry Veteran, Loïc Vincent, Ph.D., as Chief Scientific Officer
GlobeNewswire Inc.
Apr 01, 2025 11:30 AM GMT
Strengthens leadership team with additional key appointment of GaoZhong Zhu, Ph.D. as Senior Vice President of Chemistry, Manufacturing and Controls (CMC) & Technical Operations and promotion of Oliver Dolan to Principal Accounting OfficerCAMBRIDGE,